160 related articles for article (PubMed ID: 14625124)
21. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
23. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
24. Why do women doctors in the UK take hormone replacement therapy?
Isaacs AJ; Britton AR; McPherson K
J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
[TBL] [Abstract][Full Text] [Related]
25. Personal use of HRT by postmenopausal women doctors and doctors' wives in the north of Italy.
Biglia N; Cozzarella M; Ponzone R; Marenco D; Maggiorotto F; Fuso L; Sismondi P
Gynecol Endocrinol; 2004 Mar; 18(3):165-74. PubMed ID: 15255286
[TBL] [Abstract][Full Text] [Related]
26. Low use of long-term hormone replacement therapy in Denmark.
Olesen C; Steffensen FH; Sørensen HT; Nielsen GL; Olsen J; Bergman U
Br J Clin Pharmacol; 1999 Mar; 47(3):323-8. PubMed ID: 10215757
[TBL] [Abstract][Full Text] [Related]
27. Knowledge and attitude towards menopause and hormone replacement therapy in Chinese women.
Jin F; Tao M; Teng Y; Shao H; Li C; Mills E
Gynecol Obstet Invest; 2015; 79(1):40-5. PubMed ID: 25277502
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
29. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
Gambrell RD; Natrajan PK
Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
[TBL] [Abstract][Full Text] [Related]
30. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
Kuo DJ; Lee YC; Huang WF
Maturitas; 2007 Nov; 58(3):259-68. PubMed ID: 17920215
[TBL] [Abstract][Full Text] [Related]
31. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women.
Worsley R; Bell RJ; Gartoulla P; Davis SR
Menopause; 2016 Jan; 23(1):11-7. PubMed ID: 26240945
[TBL] [Abstract][Full Text] [Related]
32. The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
Armamento-Villareal RC; Napoli N; Klug T; Civitelli R
Bone; 2004 Sep; 35(3):682-8. PubMed ID: 15336604
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of symptoms possibly related to the climacteric in pre- and postmenopausal women in Linköping, Sweden.
Jansson C; Johansson S; Lindh-Astrand L; Hoffmann M; Hammar M
Maturitas; 2003 Jun; 45(2):129-35. PubMed ID: 12787971
[TBL] [Abstract][Full Text] [Related]
34. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years.
Lam PM; Leung TN; Haines C; Chung TK
Maturitas; 2003 Jun; 45(2):99-107. PubMed ID: 12787968
[TBL] [Abstract][Full Text] [Related]
35. Dietary supplement use among menopausal women attending a San Francisco health conference.
Kam IW; Dennehy CE; Tsourounis C
Menopause; 2002; 9(1):72-8. PubMed ID: 11791089
[TBL] [Abstract][Full Text] [Related]
36. Health characteristics of women beginning postmenopausal hormone therapy: have they changed since the publication of the Women's Health Initiative?
Fournier A; Fritel X; Panjo H; Zins M; Ringa V
Menopause; 2014 Jul; 21(7):687-93. PubMed ID: 24378763
[TBL] [Abstract][Full Text] [Related]
37. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
38. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
39. Hot flushes: are there effective alternatives to estrogen?
Sassarini J; Lumsden MA
Menopause Int; 2010 Jun; 16(2):81-8. PubMed ID: 20729500
[TBL] [Abstract][Full Text] [Related]
40. Achieving long-term continuance of menopausal ERT/HRT: consensus opinion of the North American Menopause Society.
Menopause; 1998; 5(2):69-76. PubMed ID: 9689198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
